Sohail Ahmad

Dr. Sohail Ahmad

Poultry Production, University of Veterinary and Animal Sciences, Lahore, Punjab, Pakistan
orcid
Looking for potential collaborators

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2024 in Animals
Verified
Journal Article
Open access
PDF file
Karim El-SabroutKarim El-Sabrout
Karim El-Sabrout
Anjum SherasiyaAnjum Sherasiya
Anjum Sherasiya
Sohail AhmadSohail Ahmad
Sohail Ahmad
SASarah Aggag
Sarah Aggag
ENEleonora Nannoni
Eleonora Nannoni
Giovanni BuonaiutoGiovanni Buonaiuto
Giovanni Buonaiuto
Rabbits are highly susceptible to environmental stress. Such stress, stemming from conventional housing conditions, can negatively impact well-being and productivity. Some of these negative consequences are increased susceptibility to diseases and infections and reduced growth rates and reproductive performance, as well as increased behavioral issues such as aggression. Environmental enrichment is the modification of the environment in which a domesticated animal lives in order to meet the species’ behavioral needs. The objective of providing enrichment is to facilitate animals in expressing natural behaviors, thereby preventing behavioral frustration and negative affective states. Several inexpensive and safe materials can be used to enrich rabbit enclosures. This review emphasizes the significance of implementing diverse environmental enrichments to alleviate stress in rabbit farming. It summarizes their effects on animal performance and welfare while exploring potential future perspectives in this field.

1 January 2020 in Meat Science
Verified
Journal Article
Closed access
AMAdeel Manzoor
Adeel Manzoor
MJMuhammad Hayat Jaspal
Muhammad Hayat Jaspal
TYTahir Yaqub
Tahir Yaqub
AHAnwaar Ul Haq
Anwaar Ul Haq
JNJamal Nasir
Jamal Nasir
MYMuhammad Kashif Yar
Muhammad Kashif Yar

9 November 2017 in South African Journal of Animal Science
Verified
Journal Article
Open access
PDF file
Sohail AhmadSohail Ahmad
Sohail Ahmad
AKA. Khalique
A. Khalique
TPT. N. Pasha
T. N. Pasha
SMS. Mehmood
S. Mehmood
KHK. Hussain
K. Hussain
MSM. Shafiq
M. Shafiq
Effect of Moringa oleifera (Lam.) pods as feed additive on egg antioxidants, chemical composition and performance of commercial layers

9 January 2021 in Tropical Animal Health and Production
Verified
Journal Article
Closed access
PDF file
MRMuhammad Faisal Riaz
Muhammad Faisal Riaz
AMAthar Mahmud
Athar Mahmud
JHJibran Hussain
Jibran Hussain
ARAbd Ur Rehman
Abd Ur Rehman
MUMuhammad Usman
Muhammad Usman
Sohail AhmadSohail Ahmad
Sohail Ahmad

3 November 2020 in medRxiv
Verified
Preprint
Open access
PDF file
SAShoaib Ashraf
Shoaib Ashraf
MIMuhammad Ahmad Imran
Muhammad Ahmad Imran
MAMoneeb Ashraf
Moneeb Ashraf
LKLarab Kalsoom
Larab Kalsoom
USUzma Nasim Siddiqui
Uzma Nasim Siddiqui
SSS Siddique
S Siddique
SUMMARY: BACKGROUND: No definitive treatment exists for Coronavirus Disease 2019 (COVID-19). Honey and Nigella sativa (HNS) have established antiviral, antibacterial, anti-inflammatory and immunomodulatory properties. Hence, we investigated efficacy of HNS against COVID-19. wide METHODS: We conducted a multicenter, placebo-controlled, randomized clinical trial at 4 centers in Pakistan. RT-PCR confirmed COVID-19 adults showing moderate or severe disease were enrolled in the study. Patients presenting with multi-organ failure, ventilator support, and chronic diseases (except diabetes mellitus and hypertension) were excluded. Patients were randomly assigned in 1:1 ratio to receive either honey (1 gm/Kg/day) and Nigella sativa seeds (80 mg/Kg/day) or placebo up-to 13 days along with standard care. The outcomes included symptom alleviation, viral clearance, and a 30-day mortality in intention-to-treat population. This trial was registered with ClinicalTrials.gov, NCT04347382 . RESULTS: Three hundred and thirteen patients - 210 moderate and 103 severe - underwent randomization from April 30 to July 29, 2020. Among these, 107 were assigned to HNS whereas 103 to placebo for moderate cases. For severe cases, 50 were given HNS and 53 were given placebos. HNS resulted in ∼50% reduction in time taken to alleviate symptoms as compared to placebo (Moderate (4 versus 7 days), Hazard Ratio [HR]: 6.11; 95% Confidence Interval [CI]: 4.23-8.84, P<0.0001 and severe (6 versus 13 days) HR: 4.04; 95% CI, 2.46-6.64, P<0.0001). HNS also cleared the virus 4 days earlier than placebo group in moderate (6 versus 10 days, HR: 5.53; 95% CI: 3.76-8.14, P<0.0001) and severe cases (8.5 versus 12 days, HR: 4.32; 95% CI: 2.62-7.13, P<0.0001). HNS further led to a better clinical score on day 6 with normal activity resumption in 63.6% versus 10.9% among moderate cases (OR: 0.07; 95% CI: 0.03-0.13, P<0.0001) and hospital discharge in 50% versus 2.8% in severe cases (OR: 0.03; 95% CI: 0.01-0.09, P<0.0001). In severe cases, mortality rate was four-fold lower in HNS group than placebo (4% versus 18.87%, OR: 0.18; 95% CI: 0.02-0.92, P=0.029). No HNS-related adverse effects were observed. CONCLUSION: HNS significantly improved symptoms, viral clearance and mortality in COVID-19 patients. Thus, HNS represents an affordable over the counter therapy and can either be used alone or in combination with other treatments to achieve potentiating effects against COVID-19. FUNDING: Funded by Smile Welfare Organization, Shaikh Zayed Medical Complex, and Services Institute of Medical Sciences.

11 May 2022 in Tropical Animal Health and Production
Verified
Journal Article
Closed access
PDF file
MMMuhammad Adeel Maqsood
Muhammad Adeel Maqsood
EKEhsaan Ullah Khan
Ehsaan Ullah Khan
SQShafqat Nawaz Qaisrani
Shafqat Nawaz Qaisrani
MRMuhammad Afzal Rashid
Muhammad Afzal Rashid
MSMuhammad Shabir Shaheen
Muhammad Shabir Shaheen
Sohail AhmadSohail Ahmad
Sohail Ahmad